Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
VERINE SR 200/MG CAP 30/CAP
- Sku : I-006587
Key features
VERINE SR 200 mg modified-release capsules contain mebeverine hydrochloride as the active ingredient. It is a direct musculotropic antispasmodic that relaxes gastrointestinal smooth muscle-likely by modulating ion fluxes, including calcium handling-thereby relieving spasms with minimal effect on normal gut motility. VERINE SR is indicated for the symptomatic treatment of irritable bowel syndrome (IBS), abdominal pain and cramps, persistent diarrhea, and flatulence associated with functional bowel disorders. Available by prescription in packs of 30 modified‑release capsules.- Brand: VERINE
- Active Ingredient: MEBEVERINE HYDROCHLORIDE
- Strength: 200mg
- Dosage Form: Modified-release capsule
- Pack Size: 30 Capsules
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Gastrointestinal
- Pharmacological Group: Antispasmodics
- Drug Class: Antispasmodic (ATC A03AA04): musculotropic smooth-muscle relaxant acting primarily on the gastrointestinal tract.
- Manufacturer: SPIMACO
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 2608200138
- Shelf Life: 36 months
- Storage: do not store above 30°c
- Gi Condition: IBS
Frequently bought together
Indications
Approved Uses
Symptomatic treatment of Irritable Bowel Syndrome (IBS), abdominal pain and cramps, persistent diarrhea, and flatulence associated with functional bowel disorders.
Dosage & Administration
Dosing by Condition
IBS/functional bowel spasm (adults): 200 mg modified-release capsule twice daily (morning and evening), preferably ~20 minutes before meals.
Initial Dose
One 200mg sustained-release capsule twice daily.
Maintenance Dose
One 200mg sustained-release capsule twice daily.
Maximum Dose
400mg per day (as two 200mg sustained-release capsules).
How to Take
Swallow the modified-release capsule whole with water; do not crush, chew, or open; take preferably about 20 minutes before meals (typically morning and evening).
Side Effects
Common Side Effects
Commonly reported: nausea and other mild GI upset; dizziness/headache; and hypersensitivity reactions such as rash/urticaria (rare but clinically important).
Side Effect Frequency
Most adverse effects are uncommon/rare and mainly hypersensitivity (e.g., rash, urticaria, angioedema, very rarely anaphylaxis); GI or CNS effects (e.g., nausea, constipation/diarrhea, headache, dizziness) are not consistently classified as common in standard labeling.
Drug Interactions
Drug Interactions
No clinically significant drug interactions are known/expected.
Interaction Severity
No clinically significant drug-drug interactions are well documented; routine interaction screening is still advised.
Storage & Patient Advice
Stopping the Medicine
May be stopped without tapering; typically discontinue when symptoms resolve or as directed by the prescriber.
Patient Counseling
Take 1 capsule (200 mg MR) twice daily, preferably ~20 minutes before meals; swallow whole with water (do not crush/chew/open). Seek urgent care for signs of allergy (rash, swelling, breathing difficulty). If symptoms persist/worsen after ~2 weeks or new alarm features occur (e.g., weight loss, bleeding), contact the prescriber.
Monitoring Requirements
No routine monitoring required. Liver function tests may be indicated if symptoms of hepatic sensitivity develop.
Pharmacology
Mechanism of Action
Direct musculotropic antispasmodic: relaxes GI smooth muscle (likely via effects on ion fluxes including calcium handling), relieving spasm with minimal effect on normal gut motility.
Onset of Action
Typically within about 1 hour (often cited range ~20-60 minutes).
Duration of Effect
Approximately 12 hours per dose for the 200 mg modified-release capsule (supports twice-daily dosing).
Half-Life
Approximately 2 hours (reported for the main circulating metabolite[s] after oral dosing; parent mebeverine has a very short/undetectable half-life due to rapid hydrolysis).
Bioavailability
Mebeverine is absorbed after oral administration and undergoes extensive first-pass metabolism to inactive metabolites; parent drug systemic levels are low, and elimination is mainly via urine as metabolites.
Product Information
Available Dosage Forms
For this SFDA-registered product: modified-release capsule (oral). Other mebeverine products may exist as immediate-release tablets (e.g., 135 mg) in some markets; oral suspension is not a standard/established mebeverine dosage form.
Composition per Dose
Each sustained-release capsule: 200mg mebeverine hydrochloride
Generic Availability
Yes
Gi Condition
IBS
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)













